The #TRCCC 28th Annual Meeting unites leaders in immuno-oncology. Interested in publishing impactful research? Join the Journal for ImmunoTherapy of Cancer Meet the Editors session Feb. 27 with Michael Lotze, MD, & Kristin Anderson, PhD, for publishing insights. Learn more https://ow.ly/NVE950Y3Tl6#TRCCC

Refer a colleague who would benefit from a SITC membership! The top referrer will be honored at #SITC26. Help grow the society and learn more here: www.sitcancer.org/connect-a-colleague#SITC26 #ConnectAColleague

My @mskcancercenter.bsky.social colleague Dr Roisin E. O'Cearbhaill discussing role of cell therapy at #tandem26 Joint session @astct.bsky.social @sitcancer.bsky.social #tcellrx #cartcells

Engage in meaningful collaboration and improve patient outcomes! Join radiation oncologists and other specialists at the 2026 Multidisciplinary Head and Neck Cancers Symposium Feb. 19-21, in Palm Desert, CA. Register now: https://ow.ly/jhV850XTtzv

It’s your last chance to visit us at #Tandem26 in booth T225! Stop by to discover #SITC membership benefits, learn about upcoming events and find out about our upcoming Scientist Interest Groups (SIGs)!

Thank you to all who joined our collaborative #Tandem26 session, we appreciate the thoughtful discussions on cellular therapy! Continue the scientific exchange at our 2026 Spring Scientific, featuring the latest on next-generation cellular therapies: https://ow.ly/FEp250XSzsE

Are you at #Tandem26 Meetings? Stop by booth T225 to learn more about SITC’s 41st Annual Meeting! #SITC26 is the perfect opportunity to share your research, learn about the latest in immuno-oncology and network with experts in the field.

Are you devoted to #makingcurereality? Become a SITC member today to join a global network of professionals dedicated to helping improve cancer patient outcomes. https://www.sitcancer.org/join

Learn essential research skills! The JITC Peer Review Mentorship Program pairs early-career researchers with senior leaders to gain hands-on peer review experience and strengthen critical evaluation skills. Submit your mentee application by Feb. 28: https://ow.ly/bmPc50Y9xBv

Visit #SITC at #Tandem26 in booth T225 to learn about Spring Scientific: Next-generation Cellular Therapies, T cell Engagers, and Combinations which will take place March 25–27 in Tucson, AZ or virtually!

The #SITC Women in Cancer Immunotherapy Network Leadership Institute is an initiative seeking to promote and elevate women in the cancer immunotherapy field. Two options to apply for: July 30–31, in Boston, MA or virtually on Sept. 10–11. https://www.sitcancer.org/career-development/win#SITC

Our latest research showing PRAME as a previously unrecognized therapeutic target in NUT carcinoma just dropped on JITC. Huge thanks to @sitcancer.bsky.social @benjamingvincent.bsky.social @alexr.bsky.social @unclineberger.bsky.social and so may others!!! jitc.bmj.com/content/14/2...

Society for Immunotherapy of Cancer is exhibiting at #Tandem26! Visit us in booth T225 and learn more about how a SITC membership can provide you with resources to grow your knowledge of #immunotherapy and advance your career.

Discuss current and emerging bispecifics for hematologic malignancies and solid tumors with SITC's #virtual Advances in Cancer Immunotherapy™: A Focus on Bispecifics and T Cell Engagers program Feb. 25. Register now: https://www.sitcancer.org/edu/aci/bispecifics-engagers#virtual#LearnACI

On #WorldCancerDay, learn about the important work SITC members accomplished in 2025 to eradicate cancer: https://www.sitcancer.org/yearinreview2025/home

Society for Immunotherapy of Cancer is proud to collaborate with ASTCT for a joint session, "Evolving Landscape of Cellular Therapy: Solid Tumors and Autoimmune Disorders," tomorrow, Feb. 5 at #Tandem26. Learn more and register here: https://tandemmeetings.swoogo.com/Tandem26

New Journal for ImmunoTherapy of Cancer article: MMP3 overexpression enhances CAR-T cell infiltration and antitumor activity in a CAF-enriched solid tumor model jitc.bmj.com/content/14/1... #JITC #MedSky 🧪

Stay ahead of the curve with multi-dimensional talks presented at Immuno-Oncology 360° conference in Boston, Feb. 10–12! Engage with our experts as they cover preclinical research, translational science, operational strategies, cell therapy and more. Learn more: https://ow.ly/jFi750XUc2p

Join SITC experts to discuss the evolving landscape of cellular therapy during a joint session at ASTCT’s #Tandemn26 Feb. 5. Gain insights into translational challenges and evolving clinical trial designs. Learn more: https://ow.ly/mLTR50XSzh8

Consider evidence, experience and future directions of neoadjuvant IO in surgical oncology with @sitcancer experts! Join us on March 5 for a joint session at the Society of Surgical Oncology 2026 Annual Meeting. Learn more: https://ow.ly/z2Ft50Y3TMJ #SSO2026

Stay in the know with #SITC! Explore our upcoming events, webinars, and important dates by looking at our calendar. Learn More: https://sitcancer.org/get-involved/events/calendar#SITC#Immunotherapy

Organized in collaboration with SITC, the 2026 WIC-APAC conference brings together leading experts and young investigators to advance patient care across the Asia-Pacific. Join us March 28–29 in Taipei, Taiwan for an inspiring scientific program. Learn more: https://ow.ly/zIvj50Y5vex

See what is new with SITC by checking out the January edition of the SITC Immune Monitor. Learn about upcoming programs and the most recent society news. Read more here: https://www.sitcancer.org/blogs/sitc-communications/2026/01/29/immune-monitor-january-2026

SITC is excited to share the 2025 Year in Review! Explore the 2025 Year in Review and learn about our efforts, goals, and how to get involved. #IO #SITCQuestfor100 https://www.sitcancer.org/yearinreview2025/home

Coming soon! Mentee applications for the Journal for ImmunoTherapy of Cancer Peer Review Mentorship Program will be collected throughout February. Learn more about the program, including key dates: https://www.sitcancer.org/publications/jitc/become-a-reviewer

Society for Immunotherapy of Cancer - Registration is Open for the 2026 Spring Scientific @sitcancer.bsky.social oncodaily.com/voices/2026-... #OncoDaily #Oncology #Cancer #Health #Medicine #MedEd #MedOnc #MedNews #SITC #SpringScientific

Call for Comment: SITC invites public review of the new draft clinical practice guideline on immunotherapy for the treatment of acute leukemia v2.0. Deadline for feedback is Feb 16 More at: https://ow.ly/lRbr50Y4Rcr #SITCGuidelines #AcuteLeukemia #Cancer

Through the collaboration of SITC, TRCCC and other key partners, the #TRCCC 28th Annual Meeting is uniting leaders across cancer immunotherapy. Join us and convene with experts Feb. 25–27 in Seven Springs, PA to advance the field. Learn more: https://ow.ly/WhHh50Y3Thf#TRCCC

New Journal for ImmunoTherapy of Cancer article: Non-superagonist CD28-based dual-signal T cell engager targeting jitc.bmj.com/content/14/1... #JITC #ImmunoSky🧪

Register for the 2026 Spring Scientific! This program will feature in-depth explorations and discussions of recent scientific breakthroughs, cutting-edge technologies, and the newest clinical studies. View the full list of faculty and sessions: www.sitcancer.org/spring-scientific-schedule-2026

Examine bispecifics with leading experts Sid Devarakonda, MD, Director of Thoracic Medical Oncology and Megan May, PharmD, BCOP, FHOPA, FAPO, Oncology Clinical Pharmacy Specialist! Join SITC's ACI: A Focus on Bispecifics and T Cell Engagers program Feb. 25: https://ow.ly/xOP150Y4k2i

Address the rapid advancements of clinical, scientific and business developments of IO! Join Society for Immunotherapy of Cancer experts at The Conference Forum’s Immuno-Oncology 360° conference in Boston, Feb. 10–12. Discover key topic areas: https://ow.ly/2tJR50XUbN2

Applications are open for the #SITC Women in Cancer Immunotherapy Network Leadership Institute! Our program is designed to empower and elevate women in the #cancer #IO field. Participate in-person July 30–31, in Boston, MA or virtually on Sept. 10–11. https://www.sitcancer.org/career-development/win

In 2025, JITC received a record number of submissions! Thanks to our editors and 1,700+ volunteer reviewers for advancing the I-O field. Want access to key leaders & emerging topics? Become a JITC Reviewer and enjoy exclusive benefits: Learn more: https://ow.ly/9WqF50Y1QrC

Join SITC and engage with experts through interactive case discussions at the 2026 Multidisciplinary Head and Neck Cancers Symposium Feb. 19-21, in Palm Desert, CA. SITC members, use the code HNC26SITC to receive access to the co-sponsor member rate. Learn more: https://ow.ly/ngx550XTtum #MHNCS26

New Journal for ImmunoTherapy of Cancer review: Steroid-sparing strategies for managing immune-related adverse events jitc.bmj.com/content/14/1...

Improve your treatment strategy with cutting-edge cancer IO programs shaped by 20+ clinical experts! Each program in our 2026 ACI series delivers practical insights to apply emerging data in clinical practice. Register now and earn free CE credit: https://www.sitcancer.org/education/aci

Don't miss your chance to join Cancer Immunotherapy Winter School! Regular registration rates and housing close tomorrow! This program will be held Feb. 16-18, 2026, in Boston, MA, or virtually. Check out the schedule and registration rates: sitcancer.org/edu/winterschool

During the free SITC Autoimmunity and Immuno-Oncology virtual summit, experts in the field will share immunotherapies and treatment strategies that minimize toxicities and mount effective, durable responses. Join us on March 18! Learn more: https://www.sitcancer.org/edu/autoimmunity-summit

The January issue of the #JITC Digest features highlighted manuscripts examining gastrointestinal malignancies, along with key insights from Dr. Kimryn Rathmell’s plenary address at the #ASCO Gastrointestinal Cancers Symposium. Read the issue: https://ow.ly/luZq50Y0Jqx#JITC

New Journal for ImmunoTherapy of Cancer article: Fully human anti-B7-H4 antibody induces lysosome-dependent ferroptosis to reverse primary resistance to PD-1 blockade jitc.bmj.com/content/14/1... 🧪 #ImmunoSky #MedSky #reasearch #cancer

Vδ1 T-cell subset appears to be responsive to PD-1 blockade therapy and is associated with survival in melanoma #gdTcells @sitcancer.bsky.social

With seven programs covering today’s most relevant clinical topics, our 2026 ACI series provides practical insights to apply immunotherapy in your practice. Address real-world challenges and earn free CE credits. Browse the full series and register now: https://www.sitcancer.org/education/aci

Earn the SITC Certificate in #Cancer #Immunotherapy to support your knowledge and skills to provide effective and safe care for patients treated with cancer immunotherapy. Learn more and register at: https://www.sitcancer.org/certificate#Cancer#Immunotherapy#IOcertificate

There is one week left of regular registration rates for #SITC Winter School. Do not miss the opportunity to attend this program! Held Feb. 16-18, 2026, in Boston, MA, or virtually. Regular registration and housing close Jan. 23, 2026. Check out the schedule: sitcancer.org/edu/winterschool

Check out an insightful commentary from Dr. Finn published recently in the open access Journal for ImmunoTherapy of Cancer! jitc.bmj.com/content/14/1...

The 2026 Spring Scientific program abstract submission window will close tomorrow. This year’s topic will explore, Next-generation Cellular Therapies, T cell Engagers, and Combinations. Submit your research for consideration: https://sitcancer.org/edu/2026-spring-scientific

New Journal for ImmunoTherapy of Cancer case report: Intratumoral dendritic cell immunotherapy controls dissemination of metastasis-initiating cancer cells, even in patients with metastatic breast cancer jitc.bmj.com/content/14/1... #JITC #MedSky

Hear directly from Society for Immunotherapy of Cancer experts and other key leaders discussing the latest data impacting immunotherapy! Join us at The Conference Forum’s Immuno-Oncology 360° conference in Boston, Feb. 10–12. Explore more: https://ow.ly/tYnf50XUbH8

🧬 Cell therapy in sarcoma: what do we know so far? Our new #OpenAccess review in the 𝘑 𝘐𝘮𝘮𝘶𝘯𝘰𝘵𝘩𝘦𝘳 𝘊𝘢𝘯𝘤𝘦𝘳 @sitcancer.bsky.social summarises the current landscape of cell therapy in sarcoma. @tkoraysahin.bsky.social @lizconnolly.bsky.social